Related Experiment Video
Updated: Jul 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
New epidemiologic trends in cholangiocarcinoma
Alina Pascale1, Olivier Rosmorduc2, Jean-Charles Duclos-Vallée1
1Hepato-Biliary Department, Paul Brousse Hospital, APHP, 14 Avenue Paul Vaillant Couturier, 94800 Villejuif, France; INSERM U1193, Université Paris-Saclay, France; FHU Hepatinov, France.
Intrahepatic cholangiocarcinoma (iCCA) incidence and mortality are rising in Western Europe, unlike extrahepatic cholangiocarcinoma (eCCA). Emerging risk factors like obesity and diabetes are increasingly linked to iCCA.
Area of Science:
- Oncology
- Gastroenterology
- Epidemiology
Background:
- Cholangiocarcinoma (CCA) is a significant biliary tract and liver malignancy.
- Intrahepatic cholangiocarcinoma (iCCA) incidence is increasing in Western Europe, while extrahepatic cholangiocarcinoma (eCCA) remains stable.
- iCCA mortality rates are rising, exceeding those of eCCA.
Purpose of the Study:
- To analyze trends in cholangiocarcinoma incidence and mortality.
- To identify established and emerging risk factors for iCCA and eCCA.
Main Methods:
- Epidemiological analysis of CCA incidence and mortality trends over three decades.
- Review of known and emerging risk factors associated with CCA subtypes.
Main Results:
- A notable increase in iCCA incidence and mortality observed in Western Europe.
- Stable or declining trends for eCCA incidence and mortality.
- Established risk factors include hepatobiliary flukes, hepatolithiasis, choledochal cysts (Asia), and primary sclerosing cholangitis (West).
- Hepatitis B/C virus infection and cirrhosis are risk factors for iCCA.
- Obesity, diabetes, and metabolic-associated fatty liver disease (MAFLD) are emerging iCCA risk factors.
Conclusions:
- iCCA represents a growing public health concern in Western countries.
- Understanding diverse risk factors is crucial for targeted prevention and treatment strategies for CCA subtypes.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

